EU MDR compliance isn't a checkbox anymore — it's the skill MedTech can't delay
The transition deadlines are closing in, Notified Bodies are already backlogged, and the professionals who can actually run this process — not just recite it — are the ones companies need most right now.
If you work anywhere near medical devices in Europe — regulatory affairs, quality, R&D, even sales — you've probably felt the shift: EU MDR has gone from "we'll get to it" to "we're out of runway." Notified Bodies are already reporting 13–18 month review timelines for complex devices. If your technical file isn't submission-ready right now, you may already be behind. Here's the conformity assessment journey, one step at a time — with a real device example at every stage.
Classification decides everything, first
Before anything else, Annex VIII's 22 rules tell you what class your device falls into — based on duration of contact, invasiveness, and whether it's active. Every later decision inherits this one.
A plain, reusable, unpowered steel grasper is a low-risk reusable instrument — Class I (Ir). No Notified Body needed; the manufacturer self-declares.
Fit that same instrument with a monopolar electrosurgical cutting tip, and it's now actively delivering energy into the body. One design change pushes it to Class IIa or IIb — and a Notified Body enters the picture for the first time.
Choosing your conformity assessment route
Once class is fixed, Article 52 tells you which Annexes are available — and for several classes, you actually get a choice between routes with very different cost and timeline implications.
Most manufacturers choose Annex IX — one Notified Body reviews the QMS and technical documentation together in a single application. The alternative, Annex X + Annex XI, splits type-examination from production QA into two certificates.
The trap: if that same pump were implantable, Article 52(4) would require full technical documentation review with no sampling — assuming sampling applies just because "it's Class IIb" is a classic, expensive mistake.
Watching for special triggers
Some devices need more than Notified Body sign-off — they're routed through an independent expert panel under the Clinical Evaluation Consultation Procedure (CECP).
Class III and implantable, this device triggers CECP under Article 54(1) by default. A later certificate renewal with no design change is exempt — but modifying the drug coating, even for the same intended purpose, requires passing a specific procedural test under MDCG guidance before skipping a fresh CECP round. Skipping that check has ended more than one submission timeline.
Building technical documentation that holds together
This is where the real work lives: GSPR matrix, risk file, clinical evaluation, labelling, PMS/PMCF — all cross-referenced so an auditor can trace any claim back to its evidence.
An auditor won't just ask "do you have a usability file?" — they'll ask you to show how a specific IEC 62366-1 usability finding fed into your risk file, and how that risk file connects back to the exact GSPR clause it's meant to satisfy. If those three documents don't tell the same story, that's a finding.
Actually working with your Notified Body
Nobody teaches this from a textbook. A Notified Body isn't an obstacle to route around — it's a working relationship you have to manage well, especially when a finding lands in your inbox.
Finding: "Section 6.2 of the Risk Management File lacks a documented post-production risk review process."
Weak response: "We monitor complaints regularly." — doesn't address the actual gap.
Strong response: names the root cause (no controlled procedure existed), the correction (a new SOP defining quarterly review), and the corrective action (retrospective review of two quarters' data against it). Same finding, very different outcome.
Surviving the audit
Whether it's a QMS audit or a mock audit, what's really being tested is whether you can defend your own file live, without hesitation — because a real auditor will ask you to.
The auditor asks the manufacturer to locate — on the spot, in the actual document, not from memory — the specific verification test supporting a GSPR claim about wear resistance. That single moment is often the difference between a smooth certification and a deficiency letter.
The deadlines aren't going away
Everything above has to happen before your transition deadline hits — 2027 for implantables, 2028 for the rest, EUDAMED registration sooner still. Manufacturers who wait are walking straight into the Notified Body capacity bottleneck already forming above.
Quick tool — which route applies to your device class?
Pick a class to see the conformity assessment route under Article 52. (Educational reference only — always verify against your device's actual intended purpose.)
Learn it by building it — not just reading about it
- You don't just learn the concepts — you build your own Technical Documentation File for a real or realistic device while you learn, checkpointed step by step.
- Walk away with 15+ reference documents you'll reuse on the job — GSPR matrices, risk file templates, CER structure, PMS/PMCF plans, and more.
- Live sessions are not theoretical lectures — strategy clinics, peer tech-file review, and a mock Notified Body audit where you defend your own file under audit-style questioning.